Cozad Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$559K Hold
4,012
0.04% 290
2025
Q4
$492K Hold
4,012
0.04% 299
2025
Q3
$445K Buy
4,012
+381
+10% +$43.3K 0.04% 310
2025
Q2
$403K Sell
3,631
-1,850
-34% -$197K 0.04% 306
2025
Q1
$614K Sell
5,481
-2,050
-27% -$212K 0.06% 245
2024
Q4
$696K Sell
7,531
-504
-6% -$45.4K 0.06% 225
2024
Q3
$674K Sell
8,035
-655
-8% -$50K 0.06% 228
2024
Q2
$596K Sell
8,690
-29,978
-78% -$2M 0.06% 236
2024
Q1
$2.83M Sell
38,668
-30,990
-44% -$2.38M 0.29% 89
2023
Q4
$5.64M Sell
69,658
-3,185
-4% -$248K 0.65% 41
2023
Q3
$5.46M Sell
72,843
-16,798
-19% -$1.29M 0.71% 37
2023
Q2
$6.91M Sell
89,641
-15,318
-15% -$1.22M 0.86% 30
2023
Q1
$8.71M Buy
104,959
+4,282
+4% +$355K 1.15% 20
2022
Q4
$8.64M Buy
100,677
+62,314
+162% +$4.93M 1.21% 16
2022
Q3
$2.37M Buy
38,363
+34,832
+986% +$2.2M 0.38% 74
2022
Q2
$218K Buy
+3,531
New +$219K 0.03% 328
2022
Q1
Sell
-1,802
Closed -$131K 360
2021
Q4
$131K Buy
+1,802
New +$124K 0.02% 347
2018
Q4
Sell
-2,592
Closed -$200K 240
2018
Q3
$200K Buy
+2,592
New +$196K 0.06% 232

Other funds holding GILD

Cozad Asset Management's GILD Position: Q1 2026 in Review

Cozad Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 4,012 shares worth $559K. The position accounts for 0.04% of the portfolio, ranked #290.

Cozad Asset Management first reported a position in GILD in Q3 2018 and has held it in 18 quarters since. The position peaked at $8.71M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Cozad Asset Management held 4,012 shares of Gilead Sciences worth $559K as of Q1 2026.
  • Cozad Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.04% of Cozad Asset Management's portfolio in Q1 2026, its #290 holding.
  • Cozad Asset Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 18 quarters since.
  • Cozad Asset Management's Gilead Sciences position peaked at $8.71M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.